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Abstract A serine protease gene was cloned from cDNA pre- 
pared from tissue isolated from human ascites. The gene codes 
for a protein of 264 amino acids, identified as human granzyme 
3 by the N-terminal amino acid sequence. Granzyme 3 has the 
expected features of the chymotrypsin family of serine proteases, 
and is closely related to other human granzymes (40-45% iden- 
tity). However, the closest granzyme 3 homologue is the recently 
characterized rat tryptase, RNK-Tryp-2 (75% identity). From 
Northern blots, granzyme 3 appears to be highly expressed in 
peripheral blood leukocytes, spleen, thymus, and lung tissues. 
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1. Introduction 
A group of related serine proteases have been isolated from 
the cytoplasmic granules of cytotoxic lymphocytes and natural 
killer cells [1,2]. Although, these granzymes appear to have a 
role in the cytolytic event, their precise function has yet to be 
elucidated [3]. Evidence suggests that they may be involved in 
the degradation of extracellular matrix, inhibition of viral and/ 
or bacterial infections, or have a specific, but as yet undefined, 
target hat triggers apoptosis [4-6]. Currently, the sequence for 
four human granzyme genes have been reported [7-13], and the 
substrate specificity for three of them have been characterized 
[13-15]. These granzymes belong to the chymotrypsin family of 
serine proteases [16], and form a subfamily with other human 
proteases isolated from cytoplasmic granules (cathepsin G and 
mast cell chymase). A fifth human granzyme, granzyme 3, has 
been purified and characterized as having trypsin-like specific- 
ity [17,18], but the cloning of this gene has not been reported. 
2. Materials and methods 
All custom synthesized oligonucleotides were purchased from 
Operon Technologies. Tissue isolated from human ascites was gener- 
ously provided by Bernard Babior (Scripps Research Institute). A 
cDNA library from this tissue, constructed in the Uni-ZAP XR vector, 
was obtained from Stratagene Cloning Systems. 
The supernatant of the amplified 2 phage cDNA library (l.3x10 ~° 
pfu/ml) was screened for serine proteases (chymotrypsin family) using 
PCR with primers complementary to active site histidine and serine 
sequences. Specifically, 1/21 of phage supernatant was PCR amplified 
with two degenerate DNA primer pools (2 /,tM of each pool, 
GTNTTRTCNGCNGCNCAYTGY and AKNGGNCCNCCNGAR- 
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Abbrev&tions." PCR, polymerase chain reaction; X-gal, 5-bromo-4- 
chloro-3-indolyl-fl-D-galactopyranoside. 
TCNC) using 1 ,ul (5 U/~tl) ofTaq Polymerase (Perkin/Elmer). The final 
volume was 50 ,ul in PCR Buffer (Perkin/Elmer) with a 40/A mineral 
oil overlay. The thermal cycling followed a 'touchdown' protocol [19] 
with initial incubations of 97°C for 5 min and then 92°C for 3 min prior 
to the addition of the Taq polymerase. Further denaturation steps were 
performed at 94°C for 30 s and extensions were done at 72°C for 30 
s except for the final extension which was for 10 rain at 72°C. Annealing 
was performed for 30 s; in the first 5 cycles at 65°C, then the next 5 
cycles at 60°C, 55°C for the next 5 cycles, and finally at 50°C for the 
final 35 cycles. The PCR reaction products were fractionated on a 5% 
polyacrylamide g l and a band corresponding to470 base pairs was cut 
out of the gel and extracted by electroelution. The purified fragment 
(phenol/chloroform extracted, ethanol precipitated) was cloned into the 
vector pCRII using a TA cloning kit (Invitrogen). Individual white 
colonies were picked from Luria-Burtani agar plates containing 40 
/2g/ml X-gal and 50/tg/ml carbenicillin for plasmid selection. After 
growth in liquid medium, plasmids were isolated (Wizard Minipreps, 
Promega) and screened for the correct insert on 5% polyacrylamide g ls 
after digestion with EcoRI. Plasmids with the correct size inserts were 
ethanol precipitated (to improve template quality), dissolved in 50 ~tl 
of water, and the inserts sequenced using M13-forward and Ml3-re- 
verse primers (Promega). The opposite strands were sequenced using 
primers complementary to sequences within the protease gene (CCT- 
CAATCAAATGATATCATGCTGG and CAGTGACTTCTCGCA- 
GGGTGTCAG). DNA was sequenced using an ABI 373A DNA Se- 
quencer and a DyeDeoxy Terminator cycle sequencing kit (Applied 
Biosystems). 
The remaining 5' portion of the granzyme 3 gene was PCR amplified 
using the primers M13-reverse, T3 (Promega), or M13-85r (CTTTA- 
TGCTTCCGGCTCGTATGTTGTGTGG) that hybridize to the 
cDNA vector (pBluescript in Uni-Zap XR, Stratagene) versus two 
primers that hybridize inside the gene (AACCACAGTGGGAGACT- 
GGCCT or GGAGGCCTCATTCTTTGAGAGAGAGTGTGC). In 
a similar way, the 3' portion of the gene was obtained by PCR amplifi- 
cations using vector primers T7 (Promega) or M13-forward versus a 
gene primer (GGAGATGCCAAAGGCCAGAAGGAT). DNA frag- 
ments corresponding to the 3' and 5' portion of the gene were cloned 
and sequenced as above. Finally, the entire mature portion of the gene 
was PCR amplified with primers (GTGTGTTATGCATATGCCAT- 
TATTGGAGGGAAAGAAGTGTCACCTCAT and CCAATAAG- 
GATCCGAATTCATTAATTTGTATGAGGCGGGACAAGGTTG), 
cloned in pCRII, and sequenced. Due to the error frequency of Taq 
polymerase, at least six different clones from each portion of the gene 
were sequenced to determine the final consensus sequence. 
Human tissue Northern blots (Clontech) were probed with a NsiI- 
BamHI fragment isolated from pCRII corresponding to the gene region 
that codes for the mature granzyme 3, Prior to hybridization, this frag- 
ment was labeled with 32p using a random priming kit (Amersham). 
Computer alignments of protein and DNA sequences were made 
using the Pileup and Gap programs (Genetics Computer Group). Un- 
less stated otherwise, all numbering of amino acids residues are based 
on the bovine chymotrypsin sequence [20]. 
3. Results and discussion 
A serine protease gene, belonging to the chymotrypsin family 
[16], was discovered by using PCR to screen a cDNA library 
of human tissue isolated from ascites. A putative start codon 
was identified near the 5' end of the full-length cDNA consen- 
sus sequence, and the following open reading frame codes for 
a serine protease of 264 amino acids (Fig. I). A polyadenylation 
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AACACATTTCATCTC~TTCTTAAATCTAAATCTTTAAAATGACTAAGTTTTCTTCC~'~ff'*C TCT~'FFF i '~CTAATAGTTGGGGCTTATATGACTCATGTC~TATGGAAAT 120 
M T K F S S F S L F F L I V G A Y M T H V C F N M E I +i 
TATTGGA GAA GAAGTGTCACCTCATTCCAGGCCATTTATGGCCT CCATC CAGTATGGCGGACATCACGTTTGTGGAGGTGTTCTGATTGATCCACAGTGGGTGCTGACAGCAGCCCA 240 
G G K E V S P H S R P F M A S I Q Y G G H H V C G G V L I D P Q W V L T A A H 41 
CTGCCAATATCGGTTTACCAAAGGCCAGTCTCCCACTGTC43TTTTAGGCGCACACTCTCTCTCAAAC~AA~~~~~ATAC~ 360 
C Q Y R F T K G Q S P T V V L G A H S L S K N E A S K Q T L E I K K F I P F S R 81 
AGTTACATCAGATCCTCAATCAAATGATATCATGCTC~TTAAGCTTCAAACAGCCC~CAATAAACATGTCAAGATGCTCCACATAAGATCCAAAAC~TTAGATCTGGAAC 480 
V T S D P Q S N D I M L V K L Q T A A K L N K H V K M L H I R S K T S L R S G T 121 
CAAATGCA~TTACTGC~GCCACCGATCCAGATTCATTAAGAC CTTCTGACACCCTC~CACTGTTACTGTCCTAAGTCGAAAACTTTG~GCCAAAGTTACTA 600 
K C K V T G W G A T D P D S L R P S D T L R E V T V T V L S R K L C N S Q S Y Y 161 
CAACGGCGAC CCTTTTATCAC CAAAGACATGGTCTGTGCAGGAGATGC CAAAC~CAGAAGGATTC CTGTAAGGGTGACTCAC~ CCCTTGATCTGTAAAGGTGTCTTCCACGCTAT 720 
N G D P F I T K D M V C A G D A K G Q K D S C K G D S G G P L I C K G V F H A I 201 
AGTCTCTGGAGGTCATGAATGTGGTGTTGC CA AAAGCCTGGAATCTACACC TGTTAACCAAGAAATACCAGAC TTGGATCAA~CCTTGTCCCGC CTCATACAAATTAAGTTAC 840 
V S G G H E C G V A T K P G I Y T L L T K K Y Q T W I K S N L V P P H T N Stop 238 
AAATAATTTTATTGGATGCACTTGCTTC TTTTTCCTAATATC~TTAGAGTTGGGTGTA~/3TAAAGCAGAGCA~TATGGGGTC CA~'Y'~q'¥~CACTTGTAAGTCATTTTATTA 960 
AGGAATCAAGTTCTTTTTCACTTGTATCACTGATGTATTTCTACCATGCTGGTTTTATTCTAAATAAAATTTAGAAGACTA~ 1058 
Fig. 1. The nucleotide sequence of the granzyme 3gene cDNA and the translated protein sequence. In the nucleotide sequence the polyadenylation 
signal site is underlined. In the amino acid sequence, the N-terminal sequence of the mature protease determined by protein sequencing [17] is 
underlined and the catalytic triad residues are in bold. 
signal and a polyA tail were found at the 3' end of the cDNA 
sequence (Fig. 1). This gene was identified as granzyme 3 since 
the predicted N-terminal sequence of the mature protein is 
identical to that reported for human granzyme 3 (Fig. 1) [17]. 
Preceding the mature protease sequence is a typical signal se- 
quence [21] most likely terminated by a short propeptide that 
ends in an acidic residue (E at -1). This propeptide sequence 
is common to many serine proteases tored in cytoplasmic 
granules (Fig. 2) [1,2] and probably reflects activation by a 
common processing peptidase. 
Human granzyme 3 has about 4045% identity to other 
members of the human granzyme group (Table 1), and has 
somewhat lower identity to bovine chymotrypsin (37%). How- 
ever, its closest homologue (75% identity) is the recently cloned 
rat tryptase, RNK-Tryp-2 [22]. Thus, these two tryptases may 
play similar roles in their respective species. A human equiva- 
lent of RNK-Tryp-2 has reportedly been cloned, but it has not 
been described as being granzyme 3 and no sequence data was 
provided [23]. 
In the granzyme 3 amino acid sequence, the predicted cata- 
lytic triad (H57, D102, and S195) and adjacent sequences fit the 
consensus model for the chymotrypsin family of serine pro- 
teases [16]. The N-terminal sequence is also nearly identical to 
that characteristic of the granzyme group of serine proteases 
( I IGGXXXXPHSRPYMA, Fig. 2) [1]. This sequence defines 
the arm whose N-terminal amino acid (I16) forms an ion pair 
with D194, after propeptide cleavage, generating the active 
form of the protease [24]. In addition, the fourth member of the 
catalytic group, $214 [25], and other residues predicted to be 
involved in defining the configuration of the active site (G43, 
G44, G140, W141, G142, L155) [24], are also conserved in 
granzyme 3. 
There is an aspartate residue in the bottom of the putative 
S1 binding site (D189) and glycines on both sides of the pocket 
(G216 and G226) as found in other proteases with trypsin-like 
specificity. This agrees with the fact that purified granzyme 3
cleaves a substrate with lysine at P1 [17,18]. It is unusual that 
granzyme 3, like RNK-Tryp-2 [22], has a glycine at residue 215, 
the top of the S1 site (usually a tryptophan, phenylalanine, or
tyrosine, Fig. 2), Thus, granzyme 3 may have a unique substrate 
specificity compared to other tryptases, distinguishing its func- 
tion from that of the other human granzyme tryptase, 
granzyme A. 
It can also be predicted that granzyme 3 has four disulfide 
bonds typically conserved in many members of the chymotryp- 
sin family (42 58, 136-201, 168-182, and 191-220, Fig. 2). 
However, the C-terminal disulfide (191-220) is missing in most 
other proteases of the granzyme group (Fig. 2) [1]. Since all 
available cysteines would be predicted to form disulfide bonds, 
granzyme 3would not have any remaining free cysteines which 
Table 1 
Percent identity among selected serine proteases 
Protease" % Identity of protease pair 
hGran3 rTryp2 hGranA hChym hMetas hGranB hGranH hCatG 
rTryp2 75 
hGranA 45 49 
hChym 41 40 43 
hMetas 40 42 40 
hGranB 42 41 41 
hGranH 41 42 44 
hCatG 39 40 41 
bChymA 37 39 33 
36 
52 41 
49 42 71 
52 42 57 56 
36 33 32 31 33 
Protease abbreviations same as in Fig. 2. 
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could form intermolecular disulfide linkages as in the formation 
of granzyme A dimers [4]. Although most granzymes are highly 
glycosylated [1], there are no consensus sequences indicative of 
N-linked glycosylation sites in granzyme 3. 
In addition to granzyme 3, we have cloned a number of serine 
proteases associated with cytoplasmic granules (granzyme B, 
hGranB 
hGranH 
hCatG 
hChym 
hGran3 
rTryp2 
hGranA 
hMetas  
bChymA 
hGranB 
hGranH 
hCatG 
hChym 
hGran3 
rTryp2 
hGranA 
hMetas 
bChymA 
hGranB 
hGranH 
hCatG 
hChym 
hGran3 
rTryp2 
hGranA 
hMetas 
bChymA 
hGranB 
hGranH 
hCatG 
hChym 
hGran3 
rTryp2 
hGranA 
hMetas  
bChymA 
hGranB 
hGranH 
hCatG 
hChym 
hGran3 
rTryp2 
hGranA 
hMetas  
bChymA 
hGranB 
hGranH 
hCatG 
hChym 
hGran3 
rTryp2 
hGranA 
hMetas  
bChymA 
-26 1 
MQP I LLLLAFLLLPRADAGEI  IGGHEAKPHSRPYMAYLMIW 
MQPFLLLLAFLLTPGAGTEE I  IGGHEAKPHSRPYMAFVQFL  
MQ PLLLLLAFL L PTGAEAGE I IGGRE SRPHSRPYMAYLQ I Q 
MLLLPLPLLLFLLCSRAEAGEI  IGGTECKPHSRPYMAYLE IV  
MTKFSSFSLFFL IVGAYMTHVCFNMEI  IGGKEVS PHSRPFMAS I QY . 
MSFSSSALVFLVAGIYMSSESFHTE I  IGGREVQPHSRPFMAS I QY . 
MRNSYRFLAS LS. VVVSLLL I  PEDVCEKI  IGGNEVTPHSRPYMVLLSL  . 
MEACVS SLLVLALGALSVGSS FGTQ I I GGREVI  PHSRPYMASLQ . . 
CGVPA I Q PVLSGL SRI VNGEEAVPGSWPWQVS LQ . . 
1 
* 50  
DQKSLKR .CC43FL I QDDFVLTAAHC ..... WGS S INVT I~IKEQEPT 
QEKSRKR . CGGI LVRKDFVLTAAHC ..... QGSS INV~IKEQERT 
SPAGQSR. CGGFLVREDFVLTAAHC ..... WGSNINVTLGAHNIQ~ 
TSNGPSKFCGGFL  I RRNFVLTAAHC ..... AGRSITVTLGA~ITEEEDT 
• . , GGHHVCGGVL IDPQWVLTAAHCQYRFTKGQSPTVVLGAHSLSKNEAS 
• . . RGKHICGGVLIHPQWVLTAAHC. . .  YSRGHSPTVVLGAHSLSKNEPM 
. . . DRKT ICAGAL IAKDWVLTAAHCNL .... NKRSQVILGAHSITREEPT  
• • RNGSHLCGGVLVHPKWVLTAAHCLAQ . . RMAQLRLVLGLHTLDSPGLT 
• DKTGFHFCGGSL IN~AAHCGV .... TTSDVVVAGEFDQGSSSEK 
50 
* i00  
QQF I PVKRPI PHPAYNP. KNFSND IMLLQLERKAKRTRAVQ PLRL PSNKA 
QQFIPVKRPI  PHPAYNP. KNF SND IMLLQLERKAK~AVRPLRL  PS SKA 
QQHITARRAIRHPQYNQ . RT I QNDIMLLQL SRRVRRN~PVAL PRAQE 
WQKLEVIKQFRHPKYNT . ST LHHD IMLLKLKEKAS LTLAVGTL PF PSQFN 
KQTLEIKKFI  PFSRVTS. DPQSNDIMLVKLQTAAK~H IRSK. T 
KQTFEIKEF I  PFSGFKS. G.. TND I ML  I KLRTAAELNKHVQLLHLRSK.  N
KQ IMLVKKEFPYPCYDP , ATREGDLKLLQLTEKAKINKYVT I LHL PKKGD 
• . . FHIKAAIQHPRYKPVPAI~LALLQLDGKVKPSRT IRPLALPSKHQ 
I QKLKIAKVFKNSKYNSL.  T I I~ ITLLKLSTAASFSQTVSAVCLPSASD 
i00 
150 
QVK PGQTCSVAGWC-QTAPLG , KH SHTLQEVKMTVQEDRKC ESDLRHYYDS 
QVKPGQLCSVAGWG . YVSMS . TLATTLQEVLLTVQKDCQC ERLFHG~IYSR 
GLRPGTLCTVAGWGR.  VSMR. RGTDTLREVQLRVQRDRQCLR I F. GSYDP 
FVPPGRMCRVAGWGRTGVLK . PGSDTLQE~PQACSHF , . RDFDH 
SLR SGTKCKVTGWGATD P S LRPSDTLREVTVTVLSRKLCNSQ SYYNGDP 
y I RDGTKCQVTGWGSTK PDVLTT SDTLQEVTVT I I SRKRCNSQ SYYNHKP 
DVK PGTMCQVAGWGRTH . NSASWSDTLREVNI  T I I DRKVCNDRNHYNFNP 
VVAAGTRCSMAGWGLTH . QGGGLSRVLRELDLQVLDTRM~SRF . . WNG 
DFAAGTTCVT GWGLTRYTNANT PDRL QQAS L PLLSNTNCKK .... YWGT 
150 
* 200 
TIE. . . LCVGDPEIKKTSFKGDSGGPLVCN.  . K. . CAQGIVSYGR .... N 
ATE. . . I CVGDPKKTQTGFKGDSGGPLVCK.  . D. . VAQGILSYG~I .... K 
RRQ... I CVGDRRERKAAPKGDSGGPLLCN. .  N . VAHGIVSYGK .... S 
NLQ.. .  LCVGNPRKTKSAFKGDSGGPLLCA. .  G.. VAQGIVSYGR .... S 
F ITKDMVCAGDAKGQKDSCKGDSGGPL ICK. .  G. VFHAIVSGG..  HECG 
V ITKDMICAGDRRGEKDSCKGDSGGPL ICK . .  G.. VFHALVSGG..  YKCG 
V IG~VMVCAGSLRGGRDSCNGDSGSPLLCE. .  G.. VFRGVTSFGL~CG 
SLSPSMVCLAADSLDQAPCKGDSGGPLVCG. .  KGRVLAGVLSFSS.  RVCT 
KIKDAMICAGA. .  SGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGS,  . STC 
2OO 
238 
NGMPPRACTKVS . SFVHWI KKTMKRY 
KGTPPGVYIKVS . HFLPWI KRTMKRL 
SGVPPEVFTRVS.  SFL PWIRTTMRSFKLLDQMETPL  
DAKPPAVFTRI  S. HYRPWINQI  LQAN 
VATKPG IYTLLTKKYQTW I KSNLVP PHTN 
I SNKPGVYTLLTKKYQTWIKSKLAPS SAH 
DPRGPGVYILLSKKHLNWI  IMT IKGAV 
D I FKPPVATAVA . PYVSWr RKVTGRSA 
STSTPGVYARVT .ALVNWVQQTLAAN 
245 
Fig. 2. An alignment of human serine proteases of the granzyme sub- 
family; granzyme B (hGranB) [7,8], granzyme H (hGranH) [10-12], 
cathepsin G (hCatG) [26], mast cell chymase (hChym) [27], granzyme 
3 (hGran3), granzyme A (hGranA) [7], and Met-ase (hMetas) [13]. The 
rat granule tryptase, RNK-Tryp-2 (rTryp2) [22], and bovine chymo- 
trypsin A (bChymA) [20] were added for comparative purposes• The 
numbering on the top and bottom of the alignment correspond to 
granzyme 3 and bovine chymotrypsin, respectively, and the catalytic 
triad residues are marked by asterisks. 
granzyme H, Met-ase, and mast cell chymase) from the cDNA 
made from ascitic tissue (data not shown). Thus, as one might 
expect, human ascites is a good source of cells involved in the 
immune response• In Northern blots, the granzyme 3 gene 
hybridizes trongly to a band of the expected size (1-1.1 kb) in 
mRNA isolated from adult human lung, spleen, thymus, and 
peripheral blood leukocytes (Fig. 3). This is not surprising since 
these tissues hould be good sources of cytolytic lymphocytes. 
Weaker hybridization signals were observed in mRNA from 
heart, liver, prostate, ovary, small intestine, and colon. Due to 
the potential for cross-hybridization to other serine protease 
genes, which appears to occur in mRNA isolated from the 
pancreas (Fig. 3), one cannot unambiguously assign the hybrid- 
ization band seen in Northern blots to the granzyme 3 mRNA. 
Due to the low levels of granzyme 3 found in activated killer 
cells [17,18], recombinant expression of the cloned granzyme 3
gene may be the best way to produce nough protein for enzy- 
matic characterization• 
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